These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9372870)

  • 1. Changes in tumor vascular permeability in response to experimental radioimmunotherapy: a comparative study of 11 xenografts.
    Blumenthal RD; Sharkey RM; Kashi R; Sides K; Stein R; Goldenberg DM
    Tumour Biol; 1997; 18(6):367-77. PubMed ID: 9372870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.
    Blumenthal RD; Sharkey RM; Natale AM; Kashi R; Wong G; Goldenberg DM
    Cancer Res; 1994 Jan; 54(1):142-51. PubMed ID: 8261435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability.
    Blumenthal RD; Kashi R; Sharkey RM; Goldenberg DM
    Int J Cancer; 1995 May; 61(4):557-66. PubMed ID: 7759161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy.
    Modrak DE; Gold DV; Goldenberg DM; Blumenthal RD
    Tumour Biol; 2003; 24(1):32-9. PubMed ID: 12743424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.
    Blumenthal RD; Taylor A; Osorio L; Ochakovskaya R; Raleigh JA; Papadopoulou M; Bloomer WD; Goldenberg DM
    Int J Cancer; 2001 Nov; 94(4):564-71. PubMed ID: 11745445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts.
    Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Watanabe N; Shuke N; Aburano T; Takayama T; Michigishi T; Tonami N
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):630-6. PubMed ID: 10541970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
    Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.
    Behr TM; Salib AL; Liersch T; Béhé M; Angerstein C; Blumenthal RD; Fayyazi A; Sharkey RM; Ringe B; Becker H; Wörmann B; Hiddemann W; Goldenberg DM; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3232s-3242s. PubMed ID: 10541369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma: effectiveness of dacarbazine.
    Stein R; Chen S; Reed L; Richel H; Goldenberg DM
    Cancer; 2002 Jan; 94(1):51-61. PubMed ID: 11815960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM; Karacay H; Johnson CR; Litwin S; Rossi EA; McBride WJ; Chang CH; Goldenberg DM
    J Nucl Med; 2009 Mar; 50(3):444-53. PubMed ID: 19223402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
    Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
    Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
    Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological factors influencing radioantibody uptake: a study of four human colonic carcinomas.
    Blumenthal RD; Sharkey RM; Kashi R; Natale AM; Goldenberg DM
    Int J Cancer; 1992 Jul; 51(6):935-41. PubMed ID: 1322378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer.
    Stein R; Juweid M; Zhang CH; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3199s-3206s. PubMed ID: 10541364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
    Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W
    Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression.
    Blumenthal RD; Alisauskas R; Lew W; Sharkey RM; Goldenberg DM
    Exp Hematol; 1998 Aug; 26(9):859-68. PubMed ID: 9694507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumor vascular activity by radioantibody therapy: implications for multiple cycle treatments.
    Blumenthal RD; Sharkey RM; Kashi R; Goldenberg DM
    Sel Cancer Ther; 1991; 7(1):9-16. PubMed ID: 1925118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
    Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct measurement of intratumor dose-rate distributions in experimental xenografts treated with 90Y-labeled radioimmunotherapy.
    Mayer R; Dillehay LE; Shao Y; Zhang YG; Song S; Bartholomew RM; Mackenson DG; Williams JR
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):147-57. PubMed ID: 7721611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.